Loading clinical trials...
Loading clinical trials...
Assessment of Optical Spectroscopy's Diagnosis Accuracy When Non-invasively and Automatically Classifying Skin Lesions in One of the Following Histological Classes: Healthy, Actinic Keratosis, in Situ Carcinoma and Invasive Carcinoma.
Conditions
Interventions
bimodal optical spectroscopy
Locations
1
France
CHR Metz Thionville
Metz, France
Start Date
October 1, 2016
Primary Completion Date
March 25, 2021
Completion Date
March 25, 2021
Last Updated
April 24, 2026
Lead Sponsor
Centre Hospitalier Régional Metz-Thionville
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions